September 23, 2014
Collaboration With Invenshure to Launch Oneome™
By Center for Individualized Medicine
Mayo Clinic and venture catalyst Invenshure have announced the launch of Oneome, a genomics interpretation company that exports Mayo’s extensive pharmacogenomics knowledge in the form of concise, actionable reports to help providers anywhere deliver the right medication at the right time. “Our own genetic makeup can have a significant impact on how our bodies process […]
Tags: center for individualized medicine, DNA, DNA Sequence, DNA Sequencing, Gene Testing, Genetics, genome, genomics, individualized medicine, Invenshure, John Logan Black, mayo clinic
February 4, 2014
Studying the Genomics of Antiplatelet Heart Medication
By Center for Individualized Medicine
Which antiplatelet medication is best after a coronary stent? The answer may lie in your genes, but heart experts differ with the Food and Drug Administration on when to do genotype testing on angioplasty patients and whether genetic testing will keep heart patients out of the emergency rooms. Around 600,000 angioplasties are performed every year in the United […]
Tags: angioplasties, angioplasty, antiplatelet medication, Brilinta, Center for Individualized Medicne, DNA Sequencing, individualized medicine, Personal Care, Personal Medicine, pharmacogenomics, Plavix, TAILOR
October 17, 2013
Discovering Smoker’s Lung Cancer Biomarker
By AJ Montpetit
Researchers at Mayo Clinic recently found that a specific pair of proteins may be a successful prognostic biomarker for identifying smoking-related lung cancers. The clinical significance of neuroendocrine (NE) differentiation in lung adenocarcinoma (AD), and the most appropriate biomarkers for this assessment, has long been debated. In the absence of a gold standard, investigators have most […]
Tags: biomarker, biomarkers, cancer, center for individualized medicine, George Vasmatzis, Lung Cancer, Personal Care, Personal Medicine, personalized care, personalized medicine, Smoke, Smoker